The future looks promising for a company born out of research by Dr. R. Mark Payne, a faculty member at the Indiana University School of Medicine.
The recent lawsuits against manufacturers of opioids (including Purdue Pharma, Johnson & Johnson, Mallinckrodt and others) bear a striking similarity to lawsuits against the tobacco companies a few years ago.
Even if the companies are found to be the proximate cause of the harm, they will argue that the damage was not “reasonably foreseeable.”
U.S. companies operating in foreign lands are still bound by U.S. laws, and U.S. laws can create a significant competitive disadvantage in certain circumstances.
Venture capital focuses generally on companies that are either pre-revenue (a company pursuing an idea, concept, product, service, etc., but not yet generating any significant revenue), or not generating enough cash flow to pay most, if not all, expenses.